China SXT Pharmaceuticals (SXTC) Competitors $0.34 -0.03 (-8.70%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.35 +0.00 (+1.43%) As of 02/21/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends SXTC vs. APM, VRAX, CMND, SNGX, ONVO, ABVC, ALZN, FRTX, MAAQ, and CANFShould you be buying China SXT Pharmaceuticals stock or one of its competitors? The main competitors of China SXT Pharmaceuticals include Aptorum Group (APM), Virax Biolabs Group (VRAX), Clearmind Medicine (CMND), Soligenix (SNGX), Organovo (ONVO), ABVC BioPharma (ABVC), Alzamend Neuro (ALZN), Fresh Tracks Therapeutics (FRTX), Mana Capital Acquisition (MAAQ), and Can-Fite BioPharma (CANF). These companies are all part of the "pharmaceutical products" industry. China SXT Pharmaceuticals vs. Aptorum Group Virax Biolabs Group Clearmind Medicine Soligenix Organovo ABVC BioPharma Alzamend Neuro Fresh Tracks Therapeutics Mana Capital Acquisition Can-Fite BioPharma Aptorum Group (NASDAQ:APM) and China SXT Pharmaceuticals (NASDAQ:SXTC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, community ranking, earnings, profitability, valuation and analyst recommendations. Does the media favor APM or SXTC? In the previous week, China SXT Pharmaceuticals had 1 more articles in the media than Aptorum Group. MarketBeat recorded 1 mentions for China SXT Pharmaceuticals and 0 mentions for Aptorum Group. Aptorum Group's average media sentiment score of 0.00 equaled China SXT Pharmaceuticals'average media sentiment score. Company Overall Sentiment Aptorum Group Neutral China SXT Pharmaceuticals Neutral Does the MarketBeat Community prefer APM or SXTC? China SXT Pharmaceuticals received 41 more outperform votes than Aptorum Group when rated by MarketBeat users. However, 68.33% of users gave Aptorum Group an outperform vote while only 61.65% of users gave China SXT Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAptorum GroupOutperform Votes4168.33% Underperform Votes1931.67% China SXT PharmaceuticalsOutperform Votes8261.65% Underperform Votes5138.35% Do institutionals & insiders have more ownership in APM or SXTC? 3.8% of Aptorum Group shares are owned by institutional investors. Comparatively, 5.0% of China SXT Pharmaceuticals shares are owned by institutional investors. 64.0% of Aptorum Group shares are owned by company insiders. Comparatively, 4.0% of China SXT Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is APM or SXTC more profitable? Company Net Margins Return on Equity Return on Assets Aptorum GroupN/A N/A N/A China SXT Pharmaceuticals N/A N/A N/A Which has stronger valuation & earnings, APM or SXTC? Aptorum Group has higher earnings, but lower revenue than China SXT Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAptorum Group$430K13.19-$2.83MN/AN/AChina SXT Pharmaceuticals$1.93M0.72-$3.10MN/AN/A Which has more risk and volatility, APM or SXTC? Aptorum Group has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, China SXT Pharmaceuticals has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. SummaryChina SXT Pharmaceuticals beats Aptorum Group on 5 of the 9 factors compared between the two stocks. Get China SXT Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SXTC vs. The Competition Export to ExcelMetricChina SXT PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.52M$7.07B$5.84B$9.15BDividend YieldN/A2.75%4.75%3.85%P/E RatioN/A5.4725.4719.00Price / Sales0.72306.08447.5876.30Price / CashN/A65.6738.0134.83Price / Book0.016.717.644.62Net Income-$3.10M$138.33M$3.18B$245.85M7 Day Performance-10.45%-2.61%-1.99%-2.68%1 Month Performance-16.76%-2.32%-0.42%-2.19%1 Year Performance-81.71%-5.31%16.51%12.84% China SXT Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SXTCChina SXT Pharmaceuticals0.2015 of 5 stars$0.34-8.7%N/A-82.9%$1.52M$1.93M0.0090Stock SplitNegative NewsHigh Trading VolumeAPMAptorum Group0.4972 of 5 stars$1.19-0.8%N/A-38.1%$6.16M$430,000.000.0030Gap UpVRAXVirax Biolabs Group0.8384 of 5 stars$1.90+1.3%N/A+93.9%$6.15M$160,000.000.005CMNDClearmind MedicineN/A$1.41+0.7%N/A-27.9%$6.02MN/A-0.75N/AGap UpSNGXSoligenix1.1949 of 5 stars$2.39-2.8%N/A-79.1%$6.00M$840,000.00-0.3220News CoverageONVOOrganovo1.1127 of 5 stars$0.39+2.1%N/A-63.1%$5.93M$110,000.00-0.3620Earnings ReportABVCABVC BioPharma1.1199 of 5 stars$0.46+8.9%N/A-41.2%$5.93M$150,000.00-0.5330News CoveragePositive NewsGap DownHigh Trading VolumeALZNAlzamend Neuro2.6121 of 5 stars$1.09+0.9%$32.00+2,835.8%-88.9%$5.92MN/A0.004Gap UpFRTXFresh Tracks TherapeuticsN/A$0.93-0.3%N/A-1.1%$5.55M$8.01M-0.6620MAAQMana Capital AcquisitionN/A$0.67-1.2%N/A-72.6%$5.44MN/A0.001High Trading VolumeCANFCan-Fite BioPharma1.9168 of 5 stars$1.53+1.0%$14.00+818.0%-11.7%$5.40M$740,000.00-0.858Analyst Forecast Related Companies and Tools Related Companies Aptorum Group Alternatives Virax Biolabs Group Alternatives Clearmind Medicine Alternatives Soligenix Alternatives Organovo Alternatives ABVC BioPharma Alternatives Alzamend Neuro Alternatives Fresh Tracks Therapeutics Alternatives Mana Capital Acquisition Alternatives Can-Fite BioPharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SXTC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis quote from Elon says it all… (AI Breakthrough)MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
